Concepedia

Imthiaz Ahamed

IA

Statistics

Publications

3

Citations

185

H-Index

3

Active since

2006

Affiliations

University of Oxford(Current)

Institute for Health Metrics and Evaluation

National Institute for Medical Research

Janssen (Netherlands)

Mwanza Intervention Trials Unit

Imthiaz Ahamed is an author at University of Oxford specializing in medicine, vaccination, and vaccine safety.

Top concepts

Publications per year

2006–2021

3

Publications

3

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 89 citations · Full text

, , +9

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 85 citations · Full text

, , +10

Asymptomatic Giant Thoracic Schwannoma

Sanjay Kumar, Muhammad Rafiq, Imthiaz Ahamed et al. · The Annals of Thoracic Surgery · 2006 · 11 citations · Full text

, , +5

1–3 of 3